Equity Research, Broker Reports, and media content on ELI LILLY & CO etc.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ELI LILLY & CO
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree offers ELI LILLY & CO research coverage from 0 professional analysts, and we have 0 reports on our platform.

Our simple but effective charting function allows for a quick scan of ELI LILLY & CO's performance over multiple time horizons.

Date Source Announcement
25/10/2016 11:25:00 PR Newswire Lilly Reports Third-Quarter 2016 Results
19/10/2016 20:49:00 PR Newswire FDA Approves Lilly's LARTRUVO™ (olaratumab) in Combination with Doxorubicin for Soft Tissue Sarcoma
18/10/2016 15:30:00 PR Newswire Lilly Announces Ambitious New Commitment to Expand Global Access to Health Care
17/10/2016 19:30:00 PR Newswire Lilly Declares Fourth-Quarter 2016 Dividend
17/10/2016 16:14:00 PR Newswire Lilly Partners with the National Cancer Institute to Accelerate Cancer Research through New Program under Cancer Moonshot Initiative
12/10/2016 14:00:00 PR Newswire Eli Lilly and Company Sponsors Arthritis Foundation 'Living Your Yes With RA,' an Initiative to Provide Resources for the Rheumatoid Arthritis Community
11/10/2016 15:00:00 PR Newswire Lilly to Participate in Credit Suisse 2016 Healthcare Conference
  • Frequency of research reports

  • Research reports on ELI LILLY & CO

  • Providers covering ELI LILLY & CO